Study to Evaluate Loncastuximab Tesirine With Rituximab Versus Immunochemotherapy in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

NCT04384484 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

440

Enrollment

INDUSTRY

Sponsor class

Conditions

Relapsed Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma

Interventions

DRUG: Loncastuximab Tesirine
DRUG: Rituximab
DRUG: Gemcitabine
DRUG: Oxaliplatin

Sponsor

ADC Therapeutics S.A.